149k views
0 votes
The inhibition of interleukin-2 synthesis by cyclosporin A and other anti-rejection drugs will act to inhibit the activity of what type(s) of cell?

1 Answer

5 votes

Final answer:

Cyclosporin A inhibits interleukin-2 synthesis, primarily affecting T-helper cells and cytotoxic T lymphocytes (CTLs), which play key roles in immune responses, including organ transplant rejection.

Step-by-step explanation:

The drug cyclosporin A is utilized in organ transplantation to prevent rejection by specifically inhibiting the synthesis of interleukin-2 (IL-2), a critical cytokine in the immune response. IL-2 predominantly acts on T cells, particularly contributing to the proliferation and activation of various T cell subsets, including T-helper (Th) cells and cytotoxic T lymphocytes (CTLs). By inhibiting IL-2, cyclosporin A hinders the activity of these T cells, effectively reducing immune responses against the transplanted organ.

Among the T cells affected, CTLs are specifically integral in transplant rejection because they can directly target and kill cells that are perceived as foreign, such as those in a transplanted organ. Similarly, Th cells provide crucial support to other immune cells, and their suppression also plays a role in reducing organ rejection. Therefore, the gross effect of IL-2 inhibition is a dampening of the body’s immune response that could otherwise lead to the destruction of the transplanted tissue.

User Ray Womack
by
8.1k points
Welcome to QAmmunity.org, where you can ask questions and receive answers from other members of our community.